Requires food manufacturers to disclose new food additives not reported to FDA.
Summary
This bill requires manufacturers of food and nonalcoholic beverages sold in New Jersey to notify the Department of Health when they use a new food additive that they have determined is generally recognized as safe (GRAS) and that has not been reported to the FDA. The required annual report is extensive and must include the basis for the GRAS conclusion, the substance’s identity and manufacturing method, dietary exposure estimates, supporting safety data, prior FDA submissions and responses, and other relevant safety information.
The Department of Health must publish the submitted reports in a searchable online database within six months of receipt, while redacting trade secrets but not the data supporting the safety determination. The bill also exempts several categories of substances from reporting, including additives already cleared by FDA through a GRAS notice, prior-sanctioned substances, certain approved food-contact substances, some historically consumed natural ingredients, and substances the commissioner has already determined are safe. Cottage food operators are excluded from the bill’s requirements.
Impact
The bill would add a new state-level disclosure and reporting regime for food additives, supplementing Title 24 of the Revised Statutes and creating obligations beyond existing federal GRAS processes. It would require manufacturers to provide detailed safety and exposure information to the New Jersey Department of Health, authorize the department to adopt implementing rules, and direct the department to maintain a public database of reports. Violations would be enforceable through civil penalties, injunctive relief, and assistance from the Attorney General, with penalties of up to $1,000 for a first offense and $5,000 for subsequent offenses.
Sentiment
Based on the bill text and sponsor statement, the measure appears to be framed positively as a consumer transparency and public-information bill. The sponsor’s stated rationale is that public access to manufacturers’ food additive assessments would help consumers make more informed choices about what they eat and drink. No committee transcript or vote record is provided, so there is no recorded legislative debate or voting sentiment available in the materials supplied.
Contention
The main likely point of contention is the balance between transparency and industry confidentiality. The bill requires publication of safety-supporting data while allowing redaction of trade secrets, but it also states that the data establishing general recognition of safety may not be omitted or redacted, which could raise concerns from manufacturers about disclosure of proprietary or sensitive information. Another possible issue is the bill’s overlap with federal FDA oversight: supporters may view it as a needed state disclosure layer, while opponents may argue it duplicates or complicates federal food-additive regulation. The bill’s broad reporting requirements and enforcement penalties could also be a concern for manufacturers, especially those introducing new ingredients or formulations.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25